Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2023The OncologistOpen Access

Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

RFRafaël FonsecaUniversity of Arkansas at Little Rock
Thierry Façon
Thierry FaçonRoswell Park Comprehensive Cancer CenterMHMahmoud HashimThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fonseca et al. (2023) studied this question.

synapsesocial.com/papers/6a0fa3f92badbc352afe785dhttps://doi.org/10.1093/oncolo/oyad053
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study2019 · 17 citations
  2. 2The real-world outcomes of multiple myeloma patients treated with daratumumab2021 · 27 citations
  3. 3Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis2022 · 30 citations
  4. 4Multiple myeloma: patient outcomes in real‐world practice2016 · 329 citations
  5. 5Reporting of Postprotocol Therapies and Attrition in Multiple Myeloma Randomized Clinical Trials2021 · 29 citations